Isolated limb perfusion for locally advanced angiosarcoma in extremities: A multi-centre study
- 15 September 2017
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 85, 114-121
- https://doi.org/10.1016/j.ejca.2017.07.023
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Role of isolated limb perfusion with recombinant human tumor necrosis factor α and melphalan in locally advanced extremity soft tissue sarcomaCancer, 2016
- Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastasesMelanoma Research, 2015
- Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor α for In-Transit Melanoma and Soft Tissue SarcomaAnnals of Surgical Oncology, 2015
- Neoadjuvant chemotherapy for primary cutaneous/soft tissue angiosarcoma: Determining tumor behavior prior to surgical resectionJournal of Surgical Oncology, 2015
- Cutaneous Angiosarcoma: A Single-Institution ExperienceAnnals of Surgical Oncology, 2013
- Outcomes of isolated limb perfusion in the treatment of extremity soft tissue sarcoma: A systematic reviewEuropean Journal of Surgical Oncology, 2013
- TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long‐term patient outcomeJournal of Surgical Oncology, 2011
- Treatment and Outcome of 82 Patients with AngiosarcomaAnnals of Surgical Oncology, 2007
- Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue SarcomaAnnals of Surgical Oncology, 2006
- Lymphangiosarcoma in postmastectomy lymphedema. A report of six cases in elephantiasis chirurgicaCancer, 1948